FDA Advisers Deciding on Pfizer/BioNTech COVID-19 Vaccine in Children

Published on October 26, 2021

An expert panel will weigh authorization of Pfizer Inc and BioNTech’s COVID-19 vaccine for children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the U.S. Food and Drug Administration.The panel’s vote is an important regulatory step in getting the…

Read Full Article (External Site)